The Middle EAST Metered Dose Inhaler Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.8%. This growth trajectory is underpinned by several factors, including the rising prevalence of respiratory diseases, increased awareness about asthma and chronic obstructive pulmonary disease (COPD), and advancements in inhaler...